Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa

Afr J Reprod Health. 2021 Feb;25(1):41-48. doi: 10.29063/ajrh2021/v25i1.5.

Abstract

Implanon NXT was introduced in South Africa (SA) in 2014 to expand the contraceptive method mix. While studies have explored patterns of implant use, data on contraceptive choice following implant removal is limited. Here, we describe contraceptive choice among 120 women requesting Implanon NXT removal, between 2017 and 2018, at an urban reproductive health clinic in Durban, SA. Among women who used the implant for three years (n=91), >50% chose to reinsert Implanon NXT. Reasons for choosing to reinsert included satisfaction with the implant, the desire for a long-acting method and having had no side effects. A third of women chose not to reinsert Implanon NXT after three years due to side effects such as problematic bleeding. Most women requesting early removal of the implant switched to male condoms, injectables or oral contraceptives. Contraceptive services should provide women with contraceptive options and allow women to make informed decisions regarding contraceptive choice, in addition to providing support and managing side effects among Implanon NXT users.

Keywords: Implanon; South Africa; contraception; informed choice; reinsertion.

MeSH terms

  • Adult
  • Choice Behavior*
  • Condoms
  • Contraception Behavior
  • Contraceptive Agents, Female / adverse effects
  • Contraceptive Agents, Female / therapeutic use*
  • Contraceptive Agents, Hormonal / adverse effects
  • Contraceptive Agents, Hormonal / therapeutic use*
  • Contraceptive Devices
  • Desogestrel / adverse effects
  • Desogestrel / therapeutic use*
  • Device Removal*
  • Female
  • Humans
  • Patient Preference*

Substances

  • Contraceptive Agents, Female
  • Contraceptive Agents, Hormonal
  • etonogestrel
  • Desogestrel